세포외기질(ECM) 생체소재 기반 필러 개발 연구
Development of Extracellular Matrix (ECM) based Dermal Filler
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Numerous efforts are being made to develop an ideal dermal filler that should be bio-compatibility, nonimmunogenicity, long-lasting and biodegradable without a toxic secretion. Biomaterials of dermal fillers are hyaluronic acid filler, calcium filler, PMMA filler and collagen filler depending on the ingredient. Although hyaluronic acid (HA) is most widely used, it has shortages such as short shelf life and low mechanical strength compare to extracellular matrix (ECM). The cartilage ECM composed of collagen type II, proteoglycans, glycosaminoglycans (GAGs) and in a minor part with glycoproteins. In this study, we developed a cartilage ECM injectable filler capable of improving biocompatibility and longevity compared with hyaluronic acid (HA) fillers. The ECM hydrogel was cross-linked by the reaction of N- (3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) for mechanical enhancement. Prepared ECM filler was compared with cross-linked HA by butanediol diglycidyle ether (BDDE), which is the most widely used natural polymers for dermal filler. In the results, the articular cartilage ECM hydrogel has great potential as a dermal filler to improve the biophysical and biological performance.
Abstract
Numerous efforts are being made to develop an ideal dermal filler that should be bio-compatibility, nonimmunogenicity, long-lasting and biodegradable without a toxic secretion. Biomaterials of dermal fillers are hyaluronic acid filler, calcium filler, PMMA filler and collagen filler depending on the ingredient. Although hyaluronic acid (HA) is most widely used, it has shortages such as short shelf life and low mechanical strength compare to extracellular matrix (ECM). The cartilage ECM composed of collagen type II, proteoglycans, glycosaminoglycans (GAGs) and in a minor part with glycoproteins. In this study, we developed a cartilage ECM injectable filler capable of improving biocompatibility and longevity compared with hyaluronic acid (HA) fillers. The ECM hydrogel was cross-linked by the reaction of N- (3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) for mechanical enhancement. Prepared ECM filler was compared with cross-linked HA by butanediol diglycidyle ether (BDDE), which is the most widely used natural polymers for dermal filler. In the results, the articular cartilage ECM hydrogel has great potential as a dermal filler to improve the biophysical and biological performance.
참고문헌 (20)
- Gilchrest BA, "Skin aging and photoaging : an overview", Journal of the American Academy of Dermatology, 21(3), pp.610~613 (1989)
- Fisher GJ, "Mechanisms of photoaging and chronological skin aging", Archives of dermatology, 138(11), pp.1462~1470 (2002)
- Fisher GJ, "Pathophysiology of premature skin aging induced by ultraviolet light", New England Journal of Medicine, 337(20), pp.1419~1429 (1997)
- Helfrich YR, "Overview of skin aging and photoaging", Dermatology nursing, 20(3), pp.177~ (2008)
- Newton VL, "Skin aging : molecular pathology, dermal remodelling and the imaging revolution", G Ital Dermatol Venereol, 150(6), pp.665~674 (2015)
- Cheng LY, "An update review on recent skin fillers", Plast Aesthet Res, 3, pp.92~99 (2016)
- Beasley KL, "Hyaluronic acid fillers : a comprehensive review", Facial Plastic Surgery, 25(02), pp.086~094 (2009)
- Fakhari A, "Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment", Acta biomaterialia, 9(7), pp.7081~7092 (2013)
- Leach JB, "Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds", Biomaterials, 26(2), pp.125~135 (2005)
- Maleki A, "Characterization of the chemical degradation of hyaluronic acid during chemical gelation in the presence of different cross-linker agents", Carbohydrate research, 342(18), pp.2776~2792 (2007)
- Schanté CE, "Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications", Carbohydrate polymers, 85(3), pp.469~489 (2011)
- Badylak SF, "Extracellular matrix as a biological scaffold material : structure and function", Acta biomaterialia, 5(1), pp.1~13 (2009)
- Theocharis AD, "Extracellular matrix structure", Advanced drug delivery reviews, 97, pp.4~27 (2016)
- Carter DR, "The mechanobiology of articular cartilage development and degeneration", Clinical Orthopaedics and Related Research, 427, pp.S69~S77 (2004)
- Sophia Fox AJ, "The basic science of articular cartilage : structure, composition, and function", Sports health, 1(6), pp.461~468 (2009)
- Hay ED, "Cell biology of extracellular matrix ed", pp.419~462 (1991), Plenum Press
- Tavsanli B, "Preparation and fracture process of high strength hyaluronic acid hydrogels cross-linked by ethylene glycol diglycidyl ether", Reactive and Functional Polymers, 109, pp.42~51 (2016)
- Werb Z., "ECM and cell surface proteolysis: regulating cellular ecology", Cell, 91(4), pp.439~442 (1997)
- Baek J, "Facile strategy involving low-temperature chemical cross-linking to enhance the physical and biological properties of hyaluronic acid hydrogel", Carbohydrate polymers, 202, pp.545~553 (2018)
- Wang MO, "Evaluation of the in vitro cytotoxicity of crosslinked biomaterials", Biomacromolecules, 14(5), pp.1321~1329 (2013)